Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Outlook Therapeutics (OTLK) over the last 7 years, with Q4 2025 value amounting to -$2.9 million.

  • Outlook Therapeutics' Change in Account Payables fell 16803.32% to -$2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.4 million, marking a year-over-year decrease of 28416.35%. This contributed to the annual value of $1.7 million for FY2025, which is 1949.84% up from last year.
  • Per Outlook Therapeutics' latest filing, its Change in Account Payables stood at -$2.9 million for Q4 2025, which was down 16803.32% from $30255.0 recorded in Q3 2025.
  • Outlook Therapeutics' Change in Account Payables' 5-year high stood at $4.2 million during Q4 2024, with a 5-year trough of -$4.6 million in Q1 2025.